CDTX - Your Daily Pharma Scoop: Cidara Reports Positive Data Verastem Beats Arzerra
Welcome to the Daily Pharma Scoop, a daily feature from the creators of the Total Pharma Tracker, a popular biopharma Marketplace service here on Seeking Alpha. In the daily scoop, we focus in on one key investment concept from the biopharma space, and also provide quick commentary on other important news, and a set of selected links to major news from the day before.
Cidara's (CDTX) positive Phase 2 rezafungin data pushed shares up
Cidara Therapeutics recently announced additional details from the results of the Phase 2 STRIVE trial of its lead candidate rezafungin ((RZF)).